When the expression of Lingo1 in hippocampal neurons was knocked down by shRNA(Lingo1), myelin sheath loss, tau phosphorylation and apoptosis were dramatically reversed, further attenuating surgery-induced cognitive impairment, demonstrating that Lingo1 might be a potential therapeutic target for the clinical treatment of POCD. This evidence concerns the gene MAPT and Cognitive impairment.